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INTRODUCTION
Stereotactic radiosurgery techniques
have been developed and used for many years
to treat a variety of small intracranial
abnormalities (Colombo et ai, 1985; Engenhart
et ai, 1990; Laksell et ai, 1971; Phillips, 1993;
Simonowa et ai, 1995). Sources ofirradiation for
this technique include X-rays, gamma rays and
charged particles. All radiosurgery techniques
intend to deliver a high focused radiation
distribution to the target volume and to minimise
the dose to surrounding normal tissues.
, The stereotactic procedure has been
described in details elsewhere (Philips, 1993;
Novotny et ai, 1996) and it can be in principal
divided into three main parts: stereotactic
localisation of lesion, treatment planning and
application of computed dose. In this
communication an attention will be paid to
treatment planning procedure, analyses of
errors connected with it and quality assurance
procedures to minimise these errors. The quality
assurance procedures will be illustrated by
examples performed in our institute for
treatment planning system (TPS) GAMMA
PLAN, used for Gamma Knife and Leksell
system, but most procedures are common for all
other TPS used with different stereotactic
instruments. A focus is paid only to physical
contributions to inaccuracies involved in the
treatment planning, subjective aspects
introduced by physician (like volume delineation,
dose decision, optimisation of plan, etc.) are not
included in the discussion.
STEREOTACTIC TREATMENT PLANNING
Treatment planning for stereotactic
radiosurgery or stereotactic radiotherapy is a
fundamentally 3-D task, and requires accurate
determination of the target volume and its
spatial relationship to nearby critical structures
in the brain. The main planning effort focuses on
defining a set of beams (shots) and computing
the volumetric distribution. The dosimetric
results must be synthesised with anatomical
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information to allow a clinical evaluation of the
treatment plan. This synthesis assumes multiple
forms allowing both qualitative evaluations, such
as isodose surface displays, and quantitative
evaluation, such as integral dose-volume
histograms. Criteria for selection of absorbed
.dose levels for individual cases are based on
three major factors: a) histology of a surgical
target, b) target volume and c) by proximity of
critical structures close to the target. The dose is
usually prescribed to periphery of the target, but
sometime, and particularly for functional
disorder treatments, the maximum dose is used.
Very often the maximum dose is limited by the
tolerance dose to critical structures, for example
to brain stem.
The stereotactic treatment planning has,
as it is obvious from the definition, two main
aspects: the first one reflects geometrical
accuracy which must be achieved during the
whole procedure; the second one takes into
account a dosimetric accuracy of dose
distribution and absorbed dose calculations. The
success of stereotactic treatment planning and
treatment depends on both aspects.
TARGET LOCALISATION
Vascular lesions, such as arteriovenous
malformations, are usually localised in
stereotactic space by cerebral angiography.
Tumour targets are typically localised in
stereotactic space with CT or MR scans. The
superiority of MR over CT for diagnostic
neuroanatomical imaging and treatment
planning is well established (Guo et ai, 1995;
Philips et ai, 1991). Often it is only appropriate
imaging modality for many brain tumours. CT
images are supposed to be distortion free and
analog angiography is superior to digital one as
regards distortion as well. The spatial accuracy
of MRI for stereotactic localisation is, however,
questionable due to magnetic resonance
distortion effects which can be up to 4-7 mm
(Walton et ai, 1995; Walton et ai, 1995; Walton
et ai, 1996). These effects are mainly caused by
inhomogeneity of the constant magnetic field
induced by the imaged object and nonlinearities
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in the gradient fields. Distortions in MR imaging
depend mainly on the MR scanner and the
stereotactic system used for localisation (Walton
et ai, 1996). Therefore it is absolutely necessary
to check the whole system (stereotactic frame +
scanner + TPS) with a suitable phantom system
for possible distortions, I.e. to apply quality
control of imaging process. Many stereotactic
TPS use image fusion to avoid problems
connected with MR distortions. Image fusion is a
technique that combine information from
separate studies into a single coherent study.
Popular image fusion techniques are based on
fiducial markers (Schat et ai, 1987) or surface
matching between volumes identified on each
modality (Kessler et ai, 1991). Again, if these
techniques are used it is necessary to check
their accuracy. CT, MR or angiographic images
are transferred to the TPS computer either on
line or with the help of a scanner (off line). Both
procedures have to be checked for an
accuracy.
After installation of a new magnetic
resonance scanner in our hospital it was
necessary to test whether MRI provides a
consistent and accurate method for stereotactic
localisation. A short study comparing
stereotactic target coordinates of chosen
anatomical structures in 10 patients submitted to
both CT and MRI investigations was performed
for this reason. Testing of image fusion between
CT and MR images for our system, which is
using fiducial markers technique, showed that
both images could be fussed within the
precision given by the image definition error; i.e.
on average within ± 0.5 mm. However, finally we
decided to perform a detailed phantom study
which could provide us with more circumstantial
information about an estimation of potential
errors in stereotactic target localisation caused
by geometric distortions in MRI. A cubical
perspex phantom which could be secured to the
base of Leksell stereotactic frame was
constructed. The insert to this phantom
consisting of array of 81 solid perspex rods (2
mm in diameter) and spaced 15 mm apart could
be positioned in the cubical phantom in three
different positions (horizontally left-right,
horizontally anterior-posterior or vertically
oriented rods) to assess the accuracy of sagittal,
coronal and axial images. The water filled
phantom with the insert was fixed to the
stereotactic frame including also four cranial
fixation posts and screws and stereotactically
investigated within the head coil of a Siemens
1T MAGNETOM Expert system using T1-, T2-
and proton density-weighted spin echo images
as well as the three dimensional T1-weighted
gradient echo. MRI of the phantom was
performed for each sequence in both axial and
coronal planes with the slab of slices situated
piecemeal in different position of the phantom
volume. The images were transferred into the
treatment planning system and the stereotactic
coordinates of the rods were determined. The
deviations between stereotactic coordinates
based on MRland real geometrical position
given by the construction of the phantom insert
were evaluated for each study. The deviations
were investigated as a function of: a) MRI
investigation sequence, b) image investigation
orientation, c) spatial position of measured
points in the investigated volume. There were
observed no dependencies of deviations on the
investigation sequences, image orientation and
spatial position of measured points. Maximal
and average deviations of stereotactic
coordinates X, Y, Z caused by image distortion
observed for our system are given in the
following Table 1.
Table 2 gives possible geometrical errors
connected with distortions (if they are not
corrected for). Two values are recorded:
maximum values reported in literature (in
brackets) and average values observed for the
system used in our department.
Image definition is the second step after
transfer of images into TPS. The image
definition procedure uses fiducial markers on
images and software to define a stereotactic
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space in which treatment planning and
treatment has to be performed. Some TPS, like
GAMMA PLAN, have self-control software
showing if the distortion in any coordinate on a
image under definition exceed permissible level
or an average and maximum values are
displayed at the end of image definition; these
values being typically around 0.5 mm and
1.0 mm, respectively. Possible displacement of
the fiducial position might result in a miscalculation
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of the whole image, when it is transformed into
stereotactic space, and therefore the localisation
accuracy throughout image could be affected.
The extent of. the miscalibration is dependent
upon the algorithms used for scaling images
. (Walton et ai, 1995; Walton et ai, 1995; Walton
et ai, 1996).
VOLUME ESTIMATION
Since the applied dose depends on the
treated volume it is necessary to establish it
carefully. Practically all TPS used for
stereotactic treatments are capable to calculate
tumour volume which was delineated either
automatically or manually on a series of images.
The accuracy of volume estimation depends on
number of slices used for estimation (slice step)
and algorithm employed for evaluation. Typical
errors are within 5-10 % of a real volume, as
one can see from Tab. 2, which were
established as a part of quality control
procedure performed for our system with a
special water phantom containing different
shaped volumes (spherical, cylindrical,
irregular). Errors caused by outlining person
might be of the same order or larger depending
on a type of lesion and are not taken into
account in this discussion. Since the dose
volume response curves established for a few
lesions (AVM, AOVM, meningioma, etc.) are not
very steep, the obtained precision in the volume
evaluation is quite sufficient, because it
represents only a few percent in the dose
applied, which could net be radiobiologically
significant.
SKULL DATA
To apply corrections for attenuation of
radiation beams passing through different
thickness of intracranial volume data for skull
have to be introduced into TPS. This is done for
some systems either by automatic outlining of
skull periphery on all CT or MR images or by
introducing data measured with the help of a
special helmet fixed to the stereotactic frame
(for example for Leksell system). The data are
collected by manual measurement of distances
from the helmet to skull and then transferred to
TPS. A correct transfer of data has to be
routinely checked for possible errors. The
GAMA PLAN TPS for example interpolate
between measured data some more points and
displays 3-D outline of the skull· for. a routine
quality control check. Any wrong measured or
interpolated data can be detected on 3-D
display as a "horns" or "holes" in the skull
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outline. Testing this procedure for Leksell
system shown that only errors larger than 2 cm
can be detected, but these errors can cause
changes in absorbed dose evaluation of about
1-2 % depending on the position of erroneous
reading in respect to a treated lesion, number
of shots and collimator used. Skull
measurements have to be performed with a
maximum care and transferred data to TPS
have to be checked for misprinting errors to
minimise error in absorbed dose calculation. On
the other hand, a daily skull measurements with
adapted helmet tool are used in our department
as a one of routine quality control procedures
during fractionated stereotactic radiotherapy.
DOSIMETRIC DATA
For dose calculations in stereotactic
TPSs, the characteristics of the individual
photon beams are described by their radial and
axial dosimetric properties. Since most of the
used beams have a circular cross section, they
are radially symmetrical. As a result the
absorbed dose profiles determined
perpendicularly to the beam axis are sufficient to
describe the beams. Extremely narrow
tolerances used in the manufacturing of
individual collimators and other parts affecting
the radiation field in Gamma Knife permit all
beam channels to be considered identical. The
characteristic of a single beam can be therefore
used for all other beams of the same size for the
purpose of dose calculation. For Iinac
stereotactic based systems the data must be
measured individually for each collimator and
beam.
Beam profiles are measured with the
help of films (either classical or chromic),
semiconductor detectors, diamond detector or
very small ionisation chambers. All methods
have certain limitations and precision. It can be
concluded that dose profiles for gamma beams
in Gamma Knife are measured with the
geometrical precision within ± 0.2 mm and
dosimetric precision of 1-2 % (Philips, 1993) and
more or less the same values could be reached
for Iinac photon beams.
Beam profiles for Gamma Knife and
their position are checked in our department
twice a year, with the help of a special testing
tool provided by Electa, for geometrical
precision as well as for dose distribution. So far,
no changes in the shape and geometry position
of beams have been observed.
Because of narrow beam conditions in
the Gamma Knife, the attenuation of a single
beam is assumed not to change with beam size
as it does in broad beam conditions. For the
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same reason the attenuation is exponential at
depth deeper than the dose maximum, if
measured along the beam axis. In the treatment
planning programme, one attenuation coefficient
is used at depths greater than 10 mm to
describe the axial dose characteristics of all
beams. Experiments have confirmed that the
attenuation coefficient used in Gamma Knife
dosimetry does not significantly differ from the
attenuation coefficient determined in an 18 mm
and 4 mm beam. Therefore, calculation error
caused by this approximation is less than 0.3
%. For X-ray beam of linear accelerator, where
larger beam collimators are very often used, the
attenuation coefficients can change with the size
of collimators and therefore detail
measurements have to be performed for
individual beams.
OUTPUT FACTORS
Absolute value of absorbed dose for
Gamma Knife is measured only for the largest
collimator (18 mm) to avoid problems with
establishment of electron equilibrium conditions.
For smaller collimators an output factor (Le. ratio
of absorbed dose measured for particular
collimator to dose measured for 18 mm
collimator) h~ve to be established. This is very
difficult procedure due to limitation of beam size
and detectors available. Originally output factors
for Gamma Knife have been established with
the help of small semiconductor detector and
established values were introduced into TPS. A
new measurements (Kreiner, 1996) which
employed different type of detectors (TlO,
ionisation chamber, film, semiconductors) have
shown discrepancies between used output
factors and measured ones up to 7 % for the
smallest collimator. Since the output factors are
used for absorbed dose calculations these
errors immediately influence the precision of
absorbed dose calculation. Next experimental
work will be necessary to check values of these
factors.
Similar problems are connected with the
Iinac based stereotactic systems, where usually
high energy photons (about 6 MV) are employed
for treatment and basic dosimetric problems are
even more difficult.
Table 2: Sources of errors and accuracies instereotactic treatment planning.
All accuracy values expressed in % are on the level of one standard deviation;
values in brackets give maximum reported or found values.
Source of error Geometrical accuracy Dosimetric accuracy
MR image distortions 0.5 (7) mm
CT image distortions 0.05 mm
Angiography image distortions (analog) 0.1 (5) mm
Scanner transfer 0.1 (1 ) mm
Image fusion 0.5 (2) mm
Skull measurements 0.5 mm
Image definition 0.5 (1.5) mm
Tumour volume evaluation 5 % -10 % 1-3 %
Isodose chart (profile) 0.2 mm 1-2 %
Output factors 3%
Dose rate 1.5 %
AIQorithm 0.5%
DOSE RATE DETERMINATION
Absolute dose rate is measured for
Gamma Knife with a small calibrated ionisation
chamber in a special spherical plastic phantom
designed for this purpose using dosimetric
protocols valid for absorbed dose determination
in therapeutic beams (for example IAEA
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protocol (IAEA, 1987). An accuracy of absorbed
dose evaluation is of the same order as for Co-
60 therapeutic photon beams, Le. about 1.5 %
on the level of one standard deviation. The
same phantom is used in our department for
routine quality control check every month.
Measured dose is always compared with the
calculated dose by TPS to check consistency of
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calculated and measured doses. An average
deviation between measured and TPS
calculated dose for the last four years was found
to be less than O. 6 %.
DISCUSSION
Table 2 gives an overview of error
sources and their magnitudes which can
influence precision of stereotactic treatment
planning. It is difficult to express a total
uncertainty of the geometrical or dosimetrical
contributions due to many reasons. Some
contributions could be add, but unfortunately
some of them not. For example we cannot add
volume determination, which is expressed as a
percentage deviation from the real volume with
other contributions expressed in absolute
deviations (Le. in mm). It is necessary for any
individual used procedure to calculate possible
deviations. There might be a difference in
uncertainty between on-line image transfer
compared to transfer off-line, Le. from an image
scanner or a large difference in geometric
accuracy between planning on CT or/and MRI
images. Table 2 can serve only as a guide for
an estimation of potential sources of errors and
their magnitudes.
It is necessary to take into·account that
estimation of target volume or volumes of critical
organs depends mainly on the slice thickness
and algorithm used for reconstruction and
calculation of volume. One has to keep in mind
the possible volume estimation error when
deciding the absorbed dose for a tumour with
dose distribution partially covering critical
organs (for example brain stem). Small change
in the volume, caused by the evaluation error,
can cause complication of the treatment.
Quality assurance of each step in the
treatment planning procedure is absolutely
necessary before starting stereotactic
treatments for estimation of magnitUde of
possible errors and then periodical checks are
required to prove consistency with original
values. It is practice in our department to run
simple tests for all mentioned sources of errors
every month in order to minimise error of
stereotactic treatment planning.
CONCLUSION
The treatment of brain lesions with
conformal stereotactic therapy poses severe
demands on the ability to accurately define the
target volume, accurately calculate dose
distribution and absorbed dose, etc. The
localisation precision offered· by stereotactic
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technology has a standard deviation
approximately less than 1 mm for Gamma Knife
and approximately 1.3 mm for Iinac based
systems when considering all aspects of the
process, and may exceed the diagnostic
precision. The latter is limited by both the actual
image quality and the ability of the physician to
discriminate the abnormal tissues from the
image. A good knowledge of performance of the
stereotactic system under use is a basic
requirement for performing a good stereotactic
therapy. The stereotactic treatment planning
system is a core unit in the whole stereotactic
process. Therefore, a good knOWledge of
accuracies of individual processes (inputs into
TPS) and drawbacks of the system are very
important for producing a reliable and precise
treatment plans which can be executed with
high precision. A regular quality control
procedures are necessary to check primarily
necessary accuracies of individual procedures
and secondly to control consistency of the
system during its use.
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